ASH 2019 abstract list & presentations

So far, we listed 39 abstracts from the European listed biotech companies or their partners for the ASH 2019 Annual meeting, excluding those relating to daratumumab (16 abstracts by Janssen/JNJ). Morphosys will present 7 abstracts and Oncopeptides 6. Cellectis and partners gather 4 presentations. Argenx will have 2 oral presentations, one for efgartigimod in ITP,[…]

ESMO 2019 abstract list & presentations

31 abstracts, at least, should be presented at the coming ESMO 2019 meeting on therapies or products from European biotech companies in our universe. The meeting kicks off at the end of the week. Faron managed to get a Late-Breaking Abstract spot (Faron says it was accepted as a Poster Discussion), which is quite rare[…]